Thiostrepton

Last updated
Thiostrepton [1]
Thiostrepton.png
Names
IUPAC name
N-[3-[(3-amino-3-oxoprop-1-en-2-yl)amino]-3-oxoprop-1-en-2-yl]-2-[(1R,8S,11Z,18S,25S,26R,53S,59S)-37-butan-2-yl-18-[(2S,3R)-2,3-dihydroxybutan-2-yl]-11-ethylidene-59-hydroxy-8-[(1R)-1-hydroxyethyl]-31-[(1S)-1-hydroxyethyl]-26,40,46-trimethyl-43-methylidene-6,9,16,23,28,38,41,44,47-nonaoxo-27-oxa-3,13,20,56-tetrathia-7,10,17,24,36,39,42,45,48,52,58,61,62,63,64-pentadecazanonacyclo[23.23.9.329,35.12,5.112,15.119,22.154,57.01,53.032,60]tetrahexaconta-2(64),4,12(63),19(62),21,29(61),30,32(60),33,51,54,57-dodecaen-51-yl]-1,3-thiazole-4-carboxamide
Other names
Alaninamide, Bryamycin, Thiactin
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard 100.014.304 OOjs UI icon edit-ltr-progressive.svg
EC Number
  • 215-734-9
PubChem CID
UNII
  • InChI=1S/C72H85N19O18S5/c1-14-26(3)47-63(105)78-30(7)57(99)75-28(5)56(98)76-31(8)58(100)91-72-19-18-40(66-85-43(22-111-66)59(101)77-29(6)55(97)74-27(4)54(73)96)81-52(72)42-21-112-67(83-42)49(34(11)109-69(107)41-20-37(32(9)92)36-16-17-39(79-47)51(95)50(36)80-41)89-60(102)44-24-113-68(86-44)53(71(13,108)35(12)94)90-62(104)45-23-110-65(84-45)38(15-2)82-64(106)48(33(10)93)88-61(103)46-25-114-70(72)87-46/h15-17,20-22,24-26,30-35,39,45,47-49,51-53,79,92-95,108H,4-6,14,18-19,23H2,1-3,7-13H3,(H2,73,96)(H,74,97)(H,75,99)(H,76,98)(H,77,101)(H,78,105)(H,82,106)(H,88,103)(H,89,102)(H,90,104)(H,91,100)/b38-15-/t26-,30-,31-,32-,33+,34+,35+,39+,45+,47-,48-,49-,51-,52+,53+,71+,72+/m0/s1
    Key: NSFFHOGKXHRQEW-AIHSUZKVSA-N
  • C[C@@H](O)[C@@](C)(O)[C@@H](C2=NC6=CS2)NC(C1CSC(/C(NC([C@@H](NC(C3=CS[C@]([C@]4(NC([C@@H](NC(C(NC([C@H](C)NC%10=O)=O)=C)=O)C)=O)C(C5=CSC([C@H]([C@@H](C)OC(C8=CC([C@H](C)O)=C(C=CC(N[C@]([H])%10[C@H](CC)C)[C@@H]9O)C9=N8)=O)NC6=O)=N5)N=C(C7=NC(C(NC(C(NC(C(N)=O)=C)=O)=C)=O)=CS7)CC4)=N3)=O)[C@@H](C)O)=O)=C/C)=N1)=O
Properties
C72H85N19O18S5
Molar mass 1664.83 g/mol
AppearanceWhite to off-white powder
Melting point 246 to 256 °C (475 to 493 °F; 519 to 529 K)
Insoluble
Solubility in other solventsSoluble in CHCl3, CH2Cl2, dioxane, pyridine, glacial acetic acid, DMF. Practically insoluble in the lower alcohols, nonpolar organic solvents, diluted aqueous acids or bases. May be dissolved by methanolic acid or base, but with decomposition. [2]
Hazards
GHS labelling:
GHS-pictogram-exclam.svg
Warning
H302
P264, P270, P301+P312, P330, P501
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN  verify  (what is  Yes check.svgYX mark.svgN ?)

Thiostrepton is a natural cyclic oligopeptide antibiotic of the thiopeptide class, derived from several strains of streptomycetes, such as Streptomyces azureus and Streptomyces laurentii . Thiostrepton is a natural product of the ribosomally synthesized and post-translationally modified peptide (RiPP) class.

Contents

History

Thiostrepton was discovered by Donovick et al. who described its antibacterial properties in 1955. [3] Dorothy Crowfoot Hodgkin solved the structure of thiostrepton in 1970. [4] Early in 1978, Bycroft and Gowland [5] proposed the biosynthesis of thiostrepton, which was still unclear until 2009. Several studies of thiopeptide biosynthesis [6] [7] [8] [9] have been contemporarily published in 2009 and two of them (Liao et al. and Kelly et al.) included the similar biosynthesis of thiostrepton: it's ribosomally synthesized from thiostrepton biosynthetic genes (tsr genes) and posttranslational modification is needed.[ citation needed ]

A total synthesis of thiostrepton was completed by K.C. Nicolaou, et al. in 2004. [10] [11]

Applications

Thiostrepton has been used in veterinary medicine in mastitis caused by gram-negative organisms and in dermatologic disorders. It is mostly used in complex ointments containing neomycin, nystatin, Thiostrepton and topical steroids. It is also active against gram-positive bacteria. It is notable that ointments for human usage contain neomycin, nystatin, and topical steroids, but no thiostrepton.[ citation needed ]

Thiostrepton was reported (in 2008) to exhibit activity against breast cancer cells through targeting the transcription factor forkhead box M1 (FOXM1), [12] also in 2011. [13] It has also been shown to circumvent acquired cisplatin resistance in breast cancer cells under in vitro conditions. [14]

Thiostrepton is used in molecular biology as a reagent for both positive and negative selection of genes involved in nucleotide metabolism.[ citation needed ]

Thiostrepton has also shown promise in treating osteoporosis in animal models because it can inhibit unusual osteoclast precursor cells. [15]

The antibiotic thiostrepton was identified as an insulin resistance reversal agent. Subsequent validation in ex vivo insulin-resistant mouse muscle and palmitate-induced insulin-resistant myotubes demonstrated potent insulin action restoration, possibly via upregulation of glycolysis due to attenuation of mitochondrial oxidative phosphorylation by thiostrepton. [16]

Biosynthesis

There are total 21 genes (tsrA~tsrU) in the biosynthetic gene cluster. The precursor of thiostrepton contains 58 amino acids in the peptide chain, which includes 41-aa leader peptide (LP) and 17-aa structural peptide (IASASCTTCICTCSCSS). Once the precursor is synthesized, cyclodehydratase tsrO and dehydrogenase tsrM catalyze the formation of thiazole or thiazoline from every cysteine residues in the peptide chain. After thiazole/thiazoline formation, dehydratases tsrJ, K and S then convert all the serine residues into dehydroalanines. A hetero Diels-Alder cyclization of the central dehydropiperidine (at S5, C13, and S14) has been suggested by Bycroft back to 1978 and been employed in the chemical synthesis of this core structure by Nicolaou et al. in 2005. An alternative mechanism of the dehydropiperidine formation has also been suggested by Kelly et al. in 2009. Nevertheless, based on experimental evidence, tsrN and L are suggested to be responsible for the hetero Diels-Alder cyclization. The quinaldic acid moiety is suggested to be synthesized by the nine genes tsrFAEBDUPQI from tryptophan and then results in the closure of quinaldic acid macrocycle. At last, tsrR serves as a candidate for the oxidation of the Ile residue to afford thiostrepton.[ citation needed ]

Biosynthesis of Thiostrepton.png

Alternative mechanism for the formation of the dehydropiperidine core

Alternative Mechanism for the dehydropiperidine thiopeptides biosynthesis.png

Total synthesis

In 2005, Nicolaou et al. published the total synthesis of thiostrepton. At first, they constructed the key building blocks of thiostrepton (1): dehydropiperidine core (2), thiazoline macrocycle (3), bis-dehydroalanine tail (4), and quinaldic acid macrocycle (5). Then they assembled the building blocks sequentially as shown in the synthetic scheme (compound numbers are from the reference).

Building blocks

Thiostrepton building block.png

Synthetic scheme

Total synthesis of thiostrepton.png

Related Research Articles

<span class="mw-page-title-main">Nisin</span> Chemical compound

Nisin is a polycyclic antibacterial peptide produced by the bacterium Lactococcus lactis that is used as a food preservative. It has 34 amino acid residues, including the uncommon amino acids lanthionine (Lan), methyllanthionine (MeLan), didehydroalanine (Dha), and didehydroaminobutyric acid (Dhb). These unusual amino acids are introduced by posttranslational modification of the precursor peptide. In these reactions a ribosomally synthesized 57-mer is converted to the final peptide. The unsaturated amino acids originate from serine and threonine, and the enzyme-catalysed addition of cysteine residues to the didehydro amino acids result in the multiple (5) thioether bridges.

Lantibiotics are a class of polycyclic peptide antibiotics that contain the characteristic thioether amino acids lanthionine or methyllanthionine, as well as the unsaturated amino acids dehydroalanine, and 2-aminoisobutyric acid. They belong to ribosomally synthesized and post-translationally modified peptides.

Nonribosomal peptides (NRP) are a class of peptide secondary metabolites, usually produced by microorganisms like bacteria and fungi. Nonribosomal peptides are also found in higher organisms, such as nudibranchs, but are thought to be made by bacteria inside these organisms. While there exist a wide range of peptides that are not synthesized by ribosomes, the term nonribosomal peptide typically refers to a very specific set of these as discussed in this article.

<span class="mw-page-title-main">Dactinomycin</span> Chemical compound

Dactinomycin, also known as actinomycin D, is a chemotherapy medication used to treat a number of types of cancer. This includes Wilms tumor, rhabdomyosarcoma, Ewing's sarcoma, trophoblastic neoplasm, testicular cancer, and certain types of ovarian cancer. It is given by injection into a vein.

<span class="mw-page-title-main">Epothilone</span> Class of chemical compounds

Epothilones are a class of potential cancer drugs. Like taxanes, they prevent cancer cells from dividing by interfering with tubulin, but in early trials, epothilones have better efficacy and milder adverse effects than taxanes.

Zwittermicin A is an antibiotic that has been identified from the bacterium Bacillus cereus UW85. It is a molecule of interest to agricultural industry because it has the potential to suppress plant disease due to its broad spectrum activity against certain gram positive and gram negative prokaryotic micro-organisms. The molecule is also of interest from a metabolic perspective because it represents a new structural class of antibiotic and suggests a crossover between polyketide and non-ribosomal peptide biosynthetic pathways. Zwittermicin A is linear aminopolyol.

Streptogramin A is a group of antibiotics within the larger family of antibiotics known as streptogramins. They are synthesized by the bacteria Streptomyces virginiae. The streptogramin family of antibiotics consists of two distinct groups: group A antibiotics contain a 23-membered unsaturated ring with lactone and peptide bonds while group B antibiotics are depsipeptides. While structurally different, these two groups of antibiotics act synergistically, providing greater antibiotic activity than the combined activity of the separate components. These antibiotics have until recently been commercially manufactured as feed additives in agriculture, although today there is increased interest in their ability to combat antibiotic-resistant bacteria, particularly vancomycin-resistant bacteria.

<span class="mw-page-title-main">Patellamide A</span> Chemical compound

Patellamide A is a peptide natural product produced by Prochloron didemni, a cyanobacterial symbiont of Lissoclinum patella, and was first isolated in 1981. Patellamide A is one of many didemnid peptides. Other closely related peptides include patellamides B, C, and D and trunkamide. The patellamides and trunkamide show moderate cytotoxicity and activity against multidrug resistant cancer cell lines.

A polyamine is an organic compound having more than two amino groups. Alkyl polyamines occur naturally, but some are synthetic. Alkylpolyamines are colorless, hygroscopic, and water soluble. Near neutral pH, they exist as the ammonium derivatives. Most aromatic polyamines are crystalline solids at room temperature.

Radical SAMenzymes is a superfamily of enzymes that use a [4Fe-4S]+ cluster to reductively cleave S-adenosyl-L-methionine (SAM) to generate a radical, usually a 5′-deoxyadenosyl radical (5'-dAdo), as a critical intermediate. These enzymes utilize this radical intermediate to perform diverse transformations, often to functionalize unactivated C-H bonds. Radical SAM enzymes are involved in cofactor biosynthesis, enzyme activation, peptide modification, post-transcriptional and post-translational modifications, metalloprotein cluster formation, tRNA modification, lipid metabolism, biosynthesis of antibiotics and natural products etc. The vast majority of known radical SAM enzymes belong to the radical SAM superfamily, and have a cysteine-rich motif that matches or resembles CxxxCxxC. Radical SAM enzymes comprise the largest superfamily of metal-containing enzymes.

Plantazolicin (PZN) is a natural antibiotic produced by the gram-positive soil bacterium Bacillus velezensis FZB42. PZN has specifically been identified as a selective bactericidal agent active against Bacillus anthracis, the causative agent of anthrax. This natural product is a ribosomally synthesized and post-translationally modified peptide (RiPP); it can be classified further as a thiazole/oxazole-modified microcin (TOMM) or a linear azole-containing peptide (LAP).

<span class="mw-page-title-main">Bottromycin</span> Chemical compound

Bottromycin is a macrocyclic peptide with antibiotic activity. It was first discovered in 1957 as a natural product isolated from Streptomyces bottropensis. It has been shown to inhibit methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) among other Gram-positive bacteria and mycoplasma. Bottromycin is structurally distinct from both vancomycin, a glycopeptide antibiotic, and methicillin, a beta-lactam antibiotic.

<span class="mw-page-title-main">YcaO</span>

YcaO is a protein found in bacteria which is involved in the synthesis of thiazole/oxazole modified microcin antibiotics, such as bottromycin. YcaO performs ATP dependent cyclodehydration to form the oxazole and thiazole moieties of the microcin.

Ribosomally synthesized and post-translationally modified peptides (RiPPs), also known as ribosomal natural products, are a diverse class of natural products of ribosomal origin. Consisting of more than 20 sub-classes, RiPPs are produced by a variety of organisms, including prokaryotes, eukaryotes, and archaea, and they possess a wide range of biological functions.

<span class="mw-page-title-main">Cyclothiazomycin</span> Chemical compound

The cyclothiazomycins are a group of natural products, classified as thiopeptides, which are produced by various Streptomyces species of bacteria.

Teixobactin is a peptide-like secondary metabolite of some species of bacteria, that kills some gram-positive bacteria. It appears to belong to a new class of antibiotics, and harms bacteria by binding to lipid II and lipid III, important precursor molecules for forming the cell wall.

<span class="mw-page-title-main">Nosiheptide</span> Chemical compound

Nosiheptide is a thiopeptide antibiotic produced by the bacterium Streptomyces actuosus.

<span class="mw-page-title-main">Lugdunin</span> Chemical compound

Lugdunin is an investigational antibiotic, classified as a thiazolidine-containing cyclic peptide. It was isolated in 2016 after Staphylococcus lugdunensis was identified as the species of bacteria from the human nose that suppressed growth of species of disease-causing bacteria in that part of the human microbiome.

<span class="mw-page-title-main">Thiopeptide</span> Class of peptide antibiotics

Thiopeptides are a class of peptide antibiotics produced by bacteria. They have antibiotic activity against Gram-positive bacteria, but little or no activity against Gram-negative bacteria. Many of the members of this class show activity against methicillin-resistant Staphylococcus aureus (MRSA) and are therefore subjects of research interest.

<span class="mw-page-title-main">Klebsazolicin</span> Chemical compound

Klebsazolicin (KLB) is a peptide antibiotic encoded in the genome of a gram-negative bacterium Klebsiella pneumoniae subsp. ozonae and targeting prokaryotic ribosome. Klebsazolicin is a ribosomally synthesized and post-translationally modified peptide (RiPP) and a linear azol(in)e-containing peptide (LAP).

References

  1. ↑ Merck Index , 11th Edition, 9295.
  2. ↑ Thiostrepton product page at Fermentek
  3. ↑ Donovick R, Pagano JF, Stout HA, Weinstein MJ (1955). "Thiostrepton, a new antibiotic. I. In vitro studies". Antibiot Annu. 3: 554–9. PMID   13355325.
  4. ↑ Anderson B, Crowfoot Hodgkin D, Viswamitra MA (1970). "The Structure of Thiostrepton". Nature . 225 (5229): 223–235. Bibcode:1970Natur.225..233A. doi:10.1038/225233a0. PMID   5409975. S2CID   40344493.
  5. ↑ Bycroft, Barrie W.; Gowland, Maxim S. (1978). "The structures of the highly modified peptide antibiotics micrococcin P1 and P2". Journal of the Chemical Society, Chemical Communications (6): 256. doi:10.1039/c39780000256. ISSN   0022-4936.
  6. ↑ Wieland Brown LC, Acker MG, Clardy J, Walsh CT, Fischbach MA (2009). "Thirteen posttranslational modifications convert a 14-residue peptide into the antibiotic thiocillin". Proc. Natl. Acad. Sci. U.S.A. 106 (8): 2549–53. Bibcode:2009PNAS..106.2549W. doi: 10.1073/pnas.0900008106 . PMC   2650375 . PMID   19196969.
  7. ↑ Morris RP, Leeds JA, Naegeli HU, Oberer L, Memmert K, Weber E, LaMarche MJ, Parker CN, Burrer N, Esterow S, Hein AE, Schmitt EK, Krastel P (2009). "Ribosomally synthesized thiopeptide antibiotics targeting elongation factor Tu". J. Am. Chem. Soc. 131 (16): 5946–55. doi:10.1021/ja900488a. PMID   19338336.
  8. ↑ Liao R, Duan L, Lei C, Pan H, Ding Y, Zhang Q, Chen D, Shen B, Yu Y, Liu W (2009). "Thiopeptide biosynthesis featuring ribosomally synthesized precursor peptides and conserved posttranslational modifications". Chem. Biol. 16 (2): 141–7. doi:10.1016/j.chembiol.2009.01.007. PMC   2676563 . PMID   19246004.
  9. ↑ Kelly WL, Pan L, Li C (2009). "Thiostrepton biosynthesis: prototype for a new family of bacteriocins". J. Am. Chem. Soc. 131 (12): 4327–34. doi:10.1021/ja807890a. PMID   19265401.
  10. ↑ Nicolaou, K. C.; Zak, Mark; Safina, Brian S.; Estrada, Anthony A.; Lee, Sang Hyup; Nevalainen, Marta (2005). "Total Synthesis of Thiostrepton. Assembly of Key Building Blocks and Completion of the Synthesis". Journal of the American Chemical Society. 127 (31): 11176–11183. doi:10.1021/ja052934z. ISSN   0002-7863. PMID   16076225.
  11. ↑ Nicolaou KC, Safina BS, Zak M, Lee SH, Nevalainen M, Bella M, Estrada AA, Funke C, Zécri FJ, Bulat S (2005). "Total synthesis of thiostrepton. Retrosynthetic analysis and construction of key building blocks". J. Am. Chem. Soc. 127 (31): 11159–75. doi:10.1021/ja0529337. PMID   16076224.
  12. ↑ Kwok JM, Myatt SS, Marson CM, Coombes RC, Constantinidou D, Lam EW (July 2008). "Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression". Mol. Cancer Ther. 7 (7): 2022–32. doi:10.1158/1535-7163.MCT-08-0188. PMID   18645012. S2CID   33941442.
  13. ↑ http://www.news-medical.net/news/20110822/Scientists-reveal-how-thiostrepton-blocks-FOXM1-protein-prevents-breast-cancer-development.aspx Scientists reveal how thiostrepton blocks FOXM1 protein, prevents breast cancer development. 2011
  14. ↑ Kwok JM; Peck B; Monteiro LJ; Schwenen HD; Millour J; Coombes RC; Myatt SS; Lam EW. (January 2010). "FOXM1 confers acquired cisplatin resistance in breast cancer cells". Molecular Cancer Research . 8 (1): 24–34. doi:10.1158/1541-7786.MCR-09-0432. PMC   2809047 . PMID   20068070.
  15. ↑ Masaru Ishii (February 2023). The Culprit Behind Osteoporosis - Medical Frontiers. NHK TV .
  16. ↑ Masson, S. W., Madsen, S., Cooke, K. C., Potter, M., Vegas, A. D., Carroll, L., ... & James, D. E. (2023). Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance. Elife, 12, RP86961 https://doi.org/10.7554/eLife.86961; bioRxiv doi : 10.1101/2023.03.01.530673
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.